Atrial Fibrillation

This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower  ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion

The Apple Watch is being used to help identify and track Afib in the general population.

The Apple Watch is being used to help identify and track Afib in the general population.  

Blog | Wearables | August 29, 2019
  Atrial fibrillation, or Afib, kills about 130,000 people worldwide every year. It also affects 3 to 6 million people...
Computer Simulations May Treat Most Common Heart Rhythm Disorder

The OPTIMA (Optimal Target Identification via Modelling of Arrhythmogenesis) simulator uses contrast-enhanced MRI scans to create personalized digital replicas of a patient's heart to guide catheter abation for atrial fibrillation. Image courtesy of Patrick M. Boyle and Natalia A. Trayanova.

News | EP Mapping and Imaging Systems | August 19, 2019
August 19, 2019 — Scientists at Johns Hopkins have successfully created personalized digital replicas of the upper...
Videos | EP Lab | July 26, 2019
Mark Ibrahim, M.D., FACC, assistant professor of medicine and radiology, associate program director, advanced cardiac...
Dr. Markus Krane, deputy director of the Cardiac and Vascular Surgery Unit at the DHM helped compile an atlas of the heart and discovered myosin binding protein H-like (MYBPHL) occurs only in the atria of the heart. Researchers began using it as a blood test biomarker to assess the success of atrial fibrillation ablation procedures.

Dr. Markus Krane, deputy director of the Cardiac and Vascular Surgery Unit at the DHM helped compile an atlas of the heart and discovered myosin binding protein H-like (MYBPHL) occurs only in the atria of the heart. Researchers began using it as a blood test biomarker to assess the success of atrial fibrillation ablation procedures.

Feature | Atrial Fibrillation | July 24, 2019
July 24, 2019 — Atrial fibrillation (AFib) is a common abnormal heart rhythm. It is treated either with medications or...
New Technology Improves Atrial Fibrillation Detection After Stroke
News | Atrial Fibrillation | July 19, 2019
July 19, 2019 — A new method of evaluating irregular heartbeats outperformed the approach that’s currently used widely...
Charge Density Mapping Eliminates Repeat Ablation for Atrial Fibrillation at One Year
News | EP Mapping and Imaging Systems | July 15, 2019
July 15, 2019 — Acutus Medical announced the publication of the UNCOVER AF study in Circulation: Arrhythmia and...
Innovative Health Receives FDA Clearance to Reprocess Pentaray Nav Eco High-density Mapping Catheter
News | EP Mapping and Imaging Systems | July 05, 2019
July 5, 2019 — Single-use cardiology medical device reprocessing company Innovative Health, received U.S. Food and Drug...
Veradigm Partners With American College of Cardiology on Next-generation Research Registries
News | Cardiovascular Clinical Studies | July 03, 2019
July 3, 2019 — The American College of Cardiology (ACC) has partnered with Veradigm, an Allscripts business unit, to...
Biotronik Launches Biomonitor III Injectable Cardiac Monitor in the CE Region
News | Implantable Cardiac Monitor (ICM) | July 01, 2019
July 1, 2019 – Biotronik announced the European market release of its new injectable cardiac monitor (ICM), Biomonitor...
Videos | Atrial Fibrillation | June 21, 2019
Sanjaya Gupta, M.D., electrophysiologist, St. Luke's Mid America Heart Institute, and assistant professor, University...
Global Afib Patient Registry Shows New Tools Needed to Assess Patient Risk
News | Patient Engagement | June 17, 2019
June 17, 2019 – Initial results from the AVIATOR 2 international registry were presented as late-breaking clinical...
Boston Scientific Initiates OPTION Trial of Watchman FLX
News | Left Atrial Appendage (LAA) Occluders | June 12, 2019
June 12, 2019 — Boston Scientific Corp. has initiated the OPTION trial to compare safety and effectiveness of the next-...
Algorithm Steers Catheters to Right Spot to Treat Atrial Fibrillation

Using human AFib simulations, the researchers demonstrated that their technique can stop the catheter at the right target and identify the source type with a 95.25 percent success rate. This new algorithm also is effective in scarred tissue, which makes ablation more challenging, and has a 99 percent detection rate regardless of the scar size. Image courtesy of Florida Atlantic University.

News | EP Mapping and Imaging Systems | May 28, 2019
May 28, 2019 — Researchers have developed the first algorithm that can locate patient-specific ablation targets for...
Medtronic Presents Positive Renal Denervation Results at EuroPCR 2019
News | Renal Denervation | May 23, 2019
May 23, 2019 – Investigators unveiled late-breaking clinical data from a first-of-its-kind physician sponsored clinical...
Preventice Solutions Presents Real-World Performance Data on BodyGuardian Remote Monitoring System With AI
News | ECG Monitoring Services | May 16, 2019
May 16, 2019 — Preventice Solutions presented clinical data validating its BodyGuardian Remote Monitoring System with...